Local tumor progression following lipiodol-based targeted chemoembolization of hepatocellular carcinoma: a retrospective comparison of miriplatin and epirubicin Full Text
Cancer Management and Research, 04/27/2012
Clinical Article
Iwazawa J et al. – Lipiodol–based targeted transarterial chemoembolization (TACE) using miriplatin had inferior local control rates as compared to epirubicin in patients with hepatocellular carcinoma (HCC).



